24th Annual PSG Symposium on Etiology, Pathogenesis, and Treatment of PD and Other Movement Disorders
Saturday, May 15, 2010 - 8:30 a.m. to 5:00 p.m.
Four Seasons Resort, Irving, Texas, USA
|
|
Presented by the Parkinson Study Group, Huntington Study Group, Dystonia Study Group,
Myoclonus Study Group, Tourette Syndrome Study Group, Cooperative Ataxia Group, and
Tremor Research Group
The Symposium will consist of current issues in genetic and
environmental contributions to Parkinson's disease and other movement
disorders with peer-reviewed platform and poster presentations designed
to communicate recent research advances, including new pharmacological
and non-pharmacological treatment options, in the field of Parkinson’s
disease, Huntington’s disease, ataxia, dystonia, myoclonus, Tourette’s
syndrome, tremor and other movement disorders thereby enhancing patient
care. Professionals in neurology and related disciplines as well as
practitioners, psychologists, educators, and researchers are invited to
attend. The gaps in clinical practice we wish to address are the unmet
needs pertaining to the translational and clinical evaluation, along
with the care and treatment of patients and families affected by PD and
other movement disorders.
Abstracts of platform and poster presentations representing original material will be published in the April 2010 issue of Movement Disorders.
Deadline for submission of regular abstracts is February 5, 2010 and late-breaking abstracts on February 15, 2010. More information and an abstract form can be obtained on the PSG web site at
www.Parkinson-Study-Group.org.
At the conclusion of this session, participants should be able to:
- To understand the rationale for the major approaches to investigating
the genetic causes of human disease;
- To review the current state of
knowledge regarding genetic contributions to PD and other movement
disorders;
- To understand the evidence for environmental
contributions to the cause of PD and other movement disorders;
- Identify and describe by scholarly review, oral presentation and group
discussion the current research into the diagnosis and treatment of
Parkinson’s disease (PD) and other movement disorders which may be
relevant to current treatment or which may lead to the development of
further research protocols;
- Distinguish and assess the important
advances in research and clinical treatments relating to a Parkinson's
disease and other movement disorders in terms of available treatment
options or new methodologies for clinical research;
- Explain new
pharmacological and non-pharmacological treatment options available for
Parkinson’s disease and other movement disorders in connection with
their clinical practice or with regard to further clinical research
methods;
- Interpret the mechanisms (genetic, environmental,
pathophysiology, neurobiology) linked to Parkinson’s disease and other
movement disorders when assessing Parkinson's disease or other movement
disorder patients or when developing new research protocols; and
- Employ diagnostic approaches and tools available for assessing
Parkinson’s disease and other movement disorders when diagnosing new
patients or when conducting clinical research.
Please contact
Roseanna Battista at roseanna.battista@ctcc.rochester.edu with any questions.
|
